| Upcoming events on CUREVAC N.V. |
|
| 05/23/22 | | Berenberg Bank USA Conference |
| 05/24/22 | | UBS Global Healthcare Conference |
| 05/25/22 | | Q1 2022 Earnings Release (Projected) |
| 06/09/22 | | Jefferies Healthcare Conference |
| 08/15/22 | | Interim 2022 Earnings Release (Projected) |
| 12/05/22 | | Q3 2022 Earnings Release (Projected) |
| 04/13/23 | | FY 2022 Earnings Release (Projected) |
|
| Past events on CUREVAC N.V. |
|
| 05/10/22 | | Bank of America Healthcare Conference |
| 04/28/22 | 09:00am | | FY 2021 Earnings Call |
| 04/28/22 | 07:50am | | FY 2021 Earnings Release |
| 04/20/22 | | Kempen Life Sciences Conference |
| 02/16/22 | | SVB Leerink Global Healthcare Conference |
| 12/06/21 | | Berenberg European Conference |
| 11/19/21 | 08:00am | | Q3 2021 Earnings Call |
| 11/19/21 | 02:00am | | Q3 2021 Earnings Release |
| 11/10/21 | | Society for Immunotherapy of Cancer Meeting |
| 11/09/21 | | International mRNA Health Conference |
|
| Past dividends on CUREVAC N.V. |
|
- No events available -
|
|
|
| Fiscal Period : December | 2019 | 2020 | 2021 | 2022 |
Sales
M € |
Released
Forecast
Spread | 17,4
| 48,9
53,3
-8,2% | 103
74,7
38% |
77,0
|
Operating income
(EBITDA)
M € |
Released
Forecast
Spread |
| -99,1
-151
35% | -762
-521
-46% |
-394
|
Operating profit
(EBIT)
M € |
Released
Forecast
Spread |
| -110
-162
32% | -778
-529
-47% |
-356
|
Pre-Tax Profit
(EBT)
M € |
Released
Forecast
Spread |
| -130
-122
-6,8% | -412
-525
21% |
-368
|
Net income
M € |
Released
Forecast
Spread |
| -129
-168
23% | -412
-531
22% |
-376
|
EPS
€ |
Released
Forecast
Spread | -137
| -0,98
-1,81
46% | -2,21
-3,29
33% |
-1,91
| | Announcement Date | 04/29/2020 | 04/15/2021 | 04/28/2022 | - |
|
|
|
| Fiscal Period : December | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
Sales
M € |
Released
Forecast
Spread | 5,16
53,2
-90% | 6,00
5,17
16% | 10,0
12,2
-18% | 22,4
12,4
81% | 29,4
29,3
0,22% | 41,2
4,15
893% |
23,0
|
23,0
|
23,0
|
23,0
|
Operating income
(EBITDA)
M € |
Released
Forecast
Spread |
81,0
|
|
|
|
|
|
|
|
|
|
Operating profit
(EBIT)
M € |
Released
Forecast
Spread | -36,8
-80,9
55% | -46,6
-52,8
12% | -116
-130
11% | -170
-159
-6,8% | -143
-143
0,03% | -371
-119
-211% |
-98,0
|
-40,0
|
-50,0
|
-55,0
|
Pre-Tax Profit
(EBT)
M € |
Released
Forecast
Spread | -36,7
76,5
-148% |
| -112
-141
20% |
|
| -4,56
-78,4
94% |
-98,0
|
-40,0
|
-50,0
|
-55,0
|
Net income
M € |
Released
Forecast
Spread | -36,8
76,5
-148% |
|
-141
|
|
| -1,94
-78,4
98% |
-98,0
|
-40,0
|
-50,0
|
-55,0
|
EPS
€ |
Released
Forecast
Spread | -0,24
-1,09
78% | -0,32
-0,32
0,00% |
-0,76
|
|
|
-0,42
|
-0,52
|
-0,21
|
-0,26
|
-0,29
| | Announcement Date | 11/30/2020 | 04/15/2021 | 05/26/2021 | 08/16/2021 | 12/17/2021 | 04/28/2022 | - | - | - | - | |
|
|
| Upcoming sector events for CUREVAC N.V. |
|
| |
|
| Past sector events for CUREVAC N.V. |
|
| |
|
|
|
|
Sanofi ditches mRNA COVID-19 vaccine after rivals' success |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year
